Study: HCQ Dosing in Lupus Usually Misses the Mark



(MedPage Today) — CHICAGO — When treating patients with systemic lupus erythematosus (SLE) with hydroxychloroquine (HCQ), following standard dosing recommendations risks excessive toxicity or suboptimal efficacy, a researcher warned here….



Source link : https://www.medpagetoday.com/meetingcoverage/acr/118202

Author :

Publish date : 2025-10-29 14:51:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version